Jagiellonian University Repository

Dual antiplatelet therapy and antithrombotic treatment : recommendations and controversies

pcg.skipToMenu

Dual antiplatelet therapy and antithrombotic treatment : recommendations and controversies

Show full item record

dc.contributor.author Bryniarski, Leszek [SAP20002159] pl
dc.contributor.author Pelc-Nowicka, Agnieszka pl
dc.contributor.author Zabojszcz, Michał pl
dc.contributor.author Mirek-Bryniarska, Ewa pl
dc.date.accessioned 2020-12-15T16:38:37Z
dc.date.available 2020-12-15T16:38:37Z
dc.date.issued 2009 pl
dc.identifier.issn 1897-5593 pl
dc.identifier.uri https://ruj.uj.edu.pl/xmlui/handle/item/258942
dc.language eng pl
dc.rights Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/pl/legalcode *
dc.title Dual antiplatelet therapy and antithrombotic treatment : recommendations and controversies pl
dc.type JournalArticle pl
dc.description.physical 179-189 pl
dc.description.additional Bibliogr. s. 187-189 pl
dc.identifier.weblink https://journals.viamedica.pl/cardiology_journal/article/view/21522 pl
dc.abstract.en Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention. Antiplatelet agents are the cornerstone of pharmacological treatment in interventional cardiology. However, there is a clear need for randomized trials to assess the treatment strategy of dual antiplatelet therapy in patients who also need long-term antithrombotic treatment (such as those with atrial fibrillation, prosthetic heart valve, mitral valve regurgitation or stenosis, deep vein thrombosis, pulmonary embolism, or pulmonary hypertension). In this paper we discuss trials and analyses on the use of dual antiplatelet treatment in combination with antithrombotic therapy in particular diseases, with a focus on the risk of hemorrhagic events connected with this treatment, as well as recent guidelines of the European Society of Cardiology, the American College of Cardiology, and the American Heart Association. pl
dc.subject.en antiplatelet therapy pl
dc.subject.en antithrombotic treatment pl
dc.subject.en acetylsalicylic acid pl
dc.subject.en clopidogrel pl
dc.subject.en oral anticoagulants pl
dc.subject.en acute coronary syndromes pl
dc.subject.en atrial fibrillation pl
dc.description.volume 16 pl
dc.description.number 2 pl
dc.identifier.eissn 1898-018X pl
dc.title.journal Cardiology Journal pl
dc.language.container eng pl
dc.date.accession 2020-12-15 pl
dc.affiliation Wydział Lekarski : Instytut Kardiologii pl
dc.subtype ReviewArticle pl
dc.rights.original CC-BY-NC-ND; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0 pl
dc.identifier.project ROD UJ / OP pl


Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa